Antag Therapeutics ApS: Financial statements 2020
CVR: 38402056
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Antag Therapeutics ApS (CVR 38402056) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -10,925,243 and a net result of DKK -12,353,317 compared with DKK -9,232,193 the year before. Equity in the 2020 report amounted to DKK -9,769,121. The company had 7 employees in the financial year.
- Gross Profit
- DKK -10,925,243
- Profit/Loss
- DKK -12,353,317
- Equity
- DKK -9,769,121
- Total Assets
- DKK 15,721,050
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -10.9 mio. | -12.4 mio. | -9.8 mio. | 7 |
| 2019 | - | -7.9 mio. | -9.2 mio. | 2.6 mio. | 4 |
| 2018 | - | -3.1 mio. | -4.4 mio. | 11.8 mio. | 4 |
| 2017 | - | -3.7 mio. | -3.9 mio. | 8.7 mio. | 2 |
Official annual report
How creditworthy is Antag Therapeutics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 31, 2020, Anker Gunvald Lundemose has left the board of directors of Antag Therapeutics ApS.
As of September 2, 2020, Emmanuelle Coutanceau has left the board of directors of Antag Therapeutics ApS.
Antag Therapeutics ApS has published its annual report for 2019. Gross profit came to DKK -7,866,664, and the net result was DKK -9,232,193.
As of March 11, 2020, Pieter Jeroen Bakker has joined the board of directors of Antag Therapeutics ApS.
As of March 11, 2020, Thomas Edward Needham Jr. has joined the board of directors of Antag Therapeutics ApS.
About Antag Therapeutics ApS
Antag Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Antag Therapeutics IVS. The management consists of Philip Just Larsen. The board consists of Keith Richard Leonard Jr (chair), Alexander Volker Wilhelm Mayweg, Amit Kantilal Shah and Jørgen Søberg Petersen. The company's owners include Novo Holdings A/S, Dawn Holdco SCSp and Versant Venture Capital VII, L.P.. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK -191,588,449 and a net result of DKK -200,999,582 compared with DKK -32,265,249 the year before. Equity in the 2025 report amounted to DKK 235,310.